Furthermore, we found that either over-expressing tumour necrosis factor alpha (TNF-α) or blocking soluble TNF receptor (sTNF-R) could lead to a reduction of both of the organ dysfunction endpoints (Ang2 and Thrombosis). This evidence concerns the gene ANGPT2 and deep vein thrombosis.